MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 74 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $141,000 | -25.4% | 15,039 | -5.6% | 0.06% | -11.3% |
| Q4 2021 | $189,000 | +46.5% | 15,932 | +40.6% | 0.07% | +24.6% |
| Q3 2021 | $129,000 | -39.7% | 11,335 | -5.0% | 0.06% | -35.2% |
| Q2 2021 | $214,000 | -39.7% | 11,930 | -47.9% | 0.09% | -41.3% |
| Q1 2021 | $355,000 | +29.1% | 22,912 | +1.8% | 0.15% | +31.6% |
| Q4 2020 | $275,000 | -33.6% | 22,503 | -30.2% | 0.11% | -47.5% |
| Q3 2020 | $414,000 | – | 32,237 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |